Logo Image
News
Global BulletinAll NewsFDA Approval AlertWomen in Oncology
Watch
Expert ConversationsShows & PodcastsNews & Analysis
Conferences
Publications
All JournalsEditorial BoardFor AuthorsYear in Review
More
Events
Frontline ForumSatellite Sessions
CME/CE
Resources
Awareness MonthThe Bispecifics NetworkNurse Practitioners/Physician's AssistantsPartnersSponsoredSponsored Media
Career Center

Subscribe

  • News
  • Watch
  • Conferences
  • Publications
  • Events
  • CME/CE
  • Resources
  • Career Center
  • Subscribe
  • Adverse Effects
  • Artificial Intelligence
  • Brain Cancer
  • Breast Cancer
    • HER2-Positive Breast Cancer
    • Triple-Negative Breast Cancer
  • Gastrointestinal Cancer
    • Colorectal Cancer
    • Esophageal Cancer
    • Pancreatic Cancer
    • Gastric Cancer
    • Liver Cancer
  • Genitourinary Cancers
    • Kidney Cancer
    • Bladder Cancer
    • Prostate Cancer
  • Gynecologic Cancers
    • Endometrial Cancer
    • Ovarian Cancer
    • Cervical Cancer
  • Head & Neck Cancer
  • Hematologic Oncology
    • Multiple Myeloma
    • Myelodysplastic Syndromes
    • Myeloproliferative Neoplasms
  • Infection
    • Vaccines
  • Leukemia
  • Lung Cancer
    • Small Cell Lung Cancer (SCLC)
    • Non-Small Cell Lung Cancer (NSCLC)
  • Lymphoma
  • Neuroendocrine Tumors
  • Oncology
  • Pediatric Cancers
  • Psycho-Oncology
  • Radiation Oncology
  • Sarcoma
  • Screening
  • Skin Cancer & Melanoma
  • Surgery
  • Thyroid Cancer
Spotlight -
Psycho-Oncology|
Artificial Intelligence|
Career Center|
Radiation Oncology|
Surgery
Advertisement

Candice Ford

Advertisement

Articles by Candice Ford

47 Can We Identify Factors That Predict DCIS Upgrade to Invasive Cancer at Mastectomy?

ByKelly Mackessy,Christopher Verdone,Karisa Beebe,Valerie L. Staradub, MD,Candice Ford,Kristen Skonieczny,Alexandra Haraczy,Alexandra Ford,Hyeon Jeong,Esha Parikh,Dawn Johnson Leonard
May 24th 2024

10 Wire Localization vs Radar Reflector Localization: A Comparison

ByKarisa Beebe,Elissa Dalton,Candice Ford,Lianteng Zhi,Karen Louie,Dawn J. Leonard,Dennis Witmer,Christopher Verdone,Jennifer Sims Mourtada,Valerie L. Staradub, MD
April 26th 2023
Advertisement

Latest Updated Articles



    Advertisement
    Advertisement

    Trending on CancerNetwork

    1

    BNT113/Pembrolizumab Misses PFS End Point in HPV16+ Head and Neck Cancer

    2

    RYZ101 Improves Progression-Free Survival in Previously Treated GEP-NETs

    3

    Why CAR T-Cell Therapy Before Bispecifics May Be the Ideal Multiple Myeloma Sequence

    4

    Teclistamab Vs Talquetamab After Relapse on CAR T-Cell Therapy in Multiple Myeloma

    5

    How Might IMiD Holding Therapy Impact Outcomes in R/R Multiple Myeloma?

    • About
    • Advertise
    • CureToday.com
    • OncLive.com
    • OncNursingNews.com
    • TargetedOnc.com
    • Editorial
    • Contact
    • Terms and Conditions
    • Privacy
    • Do Not Sell My Personal Information
    Contact Info

    259 Prospect Plains Rd, Bldg H
    Cranbury, NJ 08512

    Brand Logo

    © 2026 MJH Life Sciences®

    All rights reserved.

    Home
    About Us
    News
    Contact Us